![Timothy Stubbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Stubbs
Directeur/Bestuurslid bij
BLOSSOMHILL THERAPEUTICS, INC.
Profiel
Timothy Stubbs is Executive Director at Vivo Capital LLC since 2022.
Dr. Stubbs is Independent Director at Blossomhill Therapeutics, Inc. since 2024.
Dr. Stubbs was Vice President at Morgan Stanley from 2015 to 2022.
Dr. Stubbs completed an undergraduate degree at the University of Bristol in 2013.
Actieve functies van Timothy Stubbs
| Bedrijven | Functie | Begin |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-03-2024 |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Private Equity Investor | 01-03-2022 |
Eerdere bekende functies van Timothy Stubbs
| Bedrijven | Functie | Einde |
|---|---|---|
| MORGAN STANLEY | Corporate Officer/Principal | 01-03-2022 |
Opleiding van Timothy Stubbs
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Finance |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
